Ads
related to: nupercainal cream by novartis- Savings Card
Get Patient Savings.
Download the Savings Card.
- How Medication Works
See How Treatment Works.
Get the Facts on the Treatment.
- View Safety Profile
Review Important Safety Info.
Read Potential Side Effects.
- Patient Support
Patient Resources Available.
View FAQs & Get Support.
- Savings Card
Search results
Results From The WOW.Com Content Network
Cinchocaine (INN/BAN) or dibucaine is an amide local anesthetic.Among the most potent and toxic of the long-acting local anesthetics, current use of cinchocaine is generally restricted to spinal and topical anesthesia.
Pimecrolimus was developed by Novartis. Its development number was ascomycin derivative ASM 981. [22] The New Drug Application (NDA) was filed December 15, 2000. It received US FDA approval on December 13, 2001. [23] At its US approval, it was one of the first new eczema treatments introduced since the topical corticosteroids of the 1950s. [24]
Pages in category "Drugs developed by Novartis" The following 135 pages are in this category, out of 135 total. This list may not reflect recent changes. A.
Advanced Accelerator Applications (AAA or Adacap) is a France-based pharmaceutical group, specialized in the field of nuclear medicine. [1] The group operates in all three segments of nuclear medicine (PET, SPECT and therapy) to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases.
The origins of Galderma date back to 1961 and the founding of the Owen dermatology company in Dallas, Texas, USA by M. Owen. [5]. In 1979, Hans Schaefer founded the International Center for Dermatological Research (CIRD) in Sophia Antipolis, with the support of the CEO of L'Oréal, François Dalle, who wanted to diversify his cosmetic research into the drug sector.
Clioquinol (iodochlorhydroxyquin) tradename Entero-Vioform is an antifungal drug and antiprotozoal drug. It is neurotoxic in large doses. It is a member of a family of drugs called hydroxyquinolines which inhibit certain enzymes related to DNA replication.
Vatalanib was discovered through high-throughput screening. [2] It has been extensively investigated in Phase I, II and III clinical trials. [1] [4] Two large, randomized controlled Phase III trials have studied the effect of adding vatalanib to the FOLFOX chemotherapy regimen in people with metastatic colorectal cancer: CONFIRM-1, whose participants had not yet received any treatment for ...
Lidocaine, also known as lignocaine and sold under the brand name Xylocaine among others, is a local anesthetic of the amino amide type. [10] It is also used to treat ventricular tachycardia and ventricular fibrillation.